Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 3 Open Label Randomised Multicentre Controlled Trial of Rituxmab and Mycophenolate Mofetil Without Oral Steroids for the Treatment of Lupus Nephritis

NCT01773616 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.

NCT NCT01773616
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01773616 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 3 Open Label Randomised Multicentre Controlled Trial of Rituxmab and Mycophenolate Mofetil Without Oral Steroids for the Treatment of Lupus Nephritis
Lead sponsor
Imperial College London
Phase
Phase 3
Overall status
Terminated
Start date
April 30, 2015
Completion date
December 31, 2017
Enrollment
24 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

systemic lupus erythematosus, lupus nephritis